Your search for scully returned 41 results

The FDA expects to soon authorize omicron-targeting shots. The White House is planning to distribute them as part of a fall vaccination campaign, federal officials say.

Novavax wants its U.S. vaccine authorization to extend to a booster shot, and the U.K. has approved a two-component vaccine that directly tackles the omicron variant.

Fully 61% of previously vaccinated seniors are “very likely” to pursue vaccination with the upgraded shots expected to be authorized this fall.

Two or three COVID-19 vaccine doses provided 90% protection against invasive mechanical ventilation or in-hospital death during both the delta and omicron periods, according to new CDC data.

Long-term care operators should speed up plans to help residents boost their immunity before an expected COVID-19 surge hits, a federal official told virtual town hall attendees Tuesday.

The news, delivered by CDC Director Rochelle Walensky, is a bit of cheer amidst other new evidence that COVID-19 cases are increasing among fully vaccinated long-term care residents.

The United States is prepared to address any potential threat to the effectiveness of COVID-19 vaccines, tests and treatments posed by the new variant, according to the White House and federal health officials.

The FDA “heard loud and clear” that a simpler booster strategy was needed, its vaccine chief says. But the action may be too late to head off a winter virus surge, observers say.

A new AARP report shows encouraging trends in COVID-19 cases and vaccinations. But the steady rate of resident deaths raises concerns for the future as vaccine efficacy wanes, analysts say.

The data, from 700,000 older residents of Bavaria, resolves questions about the vaccine’s protectiveness that weren’t answered by the drugmaker’s clinical trials, investigators say.